Cory Coffey, PharmD, MS, BCACP, BCPP

Assistant Professor, Clinical Medicine; Lead Pharmacist

Pharmacist Cory Coffey in 2023Outpatient Care East
543 Taylor Ave.
Suite 3176
Columbus, OH 43203

Cory.Coffey@osumc.edu
(614) 688-6470

Cory P. Coffey, PharmD, MS, BCACP, BCPP is the Lead Clinical Pharmacist for The Ohio State University Division of General Internal Medicine Clinics and the Residency Program Director for the Ambulatory Care Pharmacy Residencies at the General Internal Medicine Clinics.

Dr. Coffey is dual certified pharmacist in Ambulatory Care and Psychiatric Pharmacy. He is actively engaged in research efforts with particular focuses on creating sustainable pharmacy services, population health, and resident education.

Education and Training

  • MS in Health-System Pharmacy Administration & Leadership, The Ohio State University, Columbus, OH
  • Residency: PGY2 Ambulatory Care, The Ohio State University College of Pharmacy/General Internal Medicine Clinics, Columbus, OH
  • Residency: PGY1 with focus in Ambulatory Care and Underserved Care, Northeast Ohio Medical University/AxessPointe Community Health Centers, Akron, OH
  • Doctor of Pharmacy, Northeast Ohio Medical University, Rootstown, OH

Selected Publications

  • McPheeters M, O’Connor E, Riley S, Kennedy S, Voisin C, Kuznacic K, Coffey C, Edlund M, Bobashev G, Jonas D. Pharmacotherapy for Adults with Alcohol Use Disorder in the Outpatient Settings: An Updated Systematic Review and Meta-Analysis. JAMA. 2023;330(17):1653–1665. doi:10.1001/jama.2023.19761

  • McPheeters M, O’Connor E, Riley S, Kennedy S, Voisin C, Kuznacic K, Coffey C, Edlund M, Bobashev G, Jonas D. Pharmacotherapy for Adults With Alcohol Use Disorder in Outpatient Settings: Systematic Review [Internet]. Rockville (MD): Agency for Healthcare Research and Quality (US); 2023 Nov. (Comparative Effectiveness Review, No. 262.) Available from: https://www.ncbi.nlm.nih.gov/books/NBK597431/ doi: 10.23970/AHRQEPCCER262

  • Seigel E, Coffey C. A Pharmacist’s Guide to do No Harm with Harm Reduction. Ohio Pharmacist. 2023;72(7):7-13.

  • Jonas D, Kahwati L, Riley S, Lee L, Coffey C, Wang S, Asher G, Berry A, Williams N, Balio C, Voisin C, Kahwati L. Screening for Latent Tuberculosis Infection in Adults: An Evidence Review for the United States Preventative Services Task Force (USPSTF). JAMA. 2023;329(17):1495–1509. doi:10.1001/jama.2023.3954.

  • Jonas D, Kahwati L, Riley S, Lee L, Coffey C, Wang S, Asher G, Berry A, Williams N, Balio C, Voisin C, Kahwati L. Screening for Latent Tuberculosis Infection in Adults: An Evidence Review for the U.S. Preventive Services Task Force. Evidence Synthesis No. 226. AHRQ Publication No. 22-05298-EF-1. Rockville, MD: Agency for Healthcare Research and Quality; 2023.

  • Kuznacic K, Coffey C, Barnes K. Impact of a Pharmacist-run Electronic Consult Service within a Network of Outpatient Primary Care Clinics. J Am Board Fam Med. 2023; doi:10.3122/jabfm.2022.220394R2.

  • Lee L, Coffey C. A Pharmacist’s Guide to Pre-Exposure Prophylaxis (PrEP). Ohio Pharmacist. 2022; 71(3): 7-13.

  • Lee L, Pollak B, Coffey C. Implementing a Collaborative Practice Agreement for HIV Pre-exposure Prophylaxis in the Primary Care Setting. J Am Pharm Assoc. 2022;doi.org/10.1016/j.japh.2022.09.011

  • Prescott D, Coffey C, Barnes K.Innovative learning in pharmacy practice: The perceived benefits and barriers to a layered learning practice model. J Am Pharm Assoc. 2020; doi:10.1016/j.japh.2020.07.011.

  • Coffey C, Awad M, Ulbrich T, Baughman K, Adorno A, Dhyanchand C. The Effect of an Interprofessional Pain Service on Nonmalignant Pain Control. Am J Health Syst Pharm. 2019. doi:10.1093/ajhp/zxy084.

  • Coffey C, Barnette D, Wenzke J, Lawrence J. Implementing a Systematic Approach to Deprescribing Proton Pump Inhibitor Therapy in the Elderly. Sr Care Pharm. 2019; 34(1): 47-55.

  • Pokorny A, Boyle J, Hoffman A, Coffey C, Schneider S. A Structured Longitudinal Professional Identity Development Curriculum for Pharmacy Students. Curr Pharm Teach Learn. 2018; 10(11): 1518-1523.